Nebius Stock: A Rotterdam Megaproject and a 2034 Cash Flow Horizon

Nebius shares slid 9.8% as rate worries and a $20–25B 2026 capex plan refocus investors on funding needs, despite 454% revenue growth.

Nebius is discovering that the distance between an ambitious blueprint and a self-funding business is measured in years, not quarters. Tuesday's 9.8% slide — following a 5.4% drop the previous session — has less to do with any single operational setback than with a market that is repricing how long it is willing to wait for the AI infrastructure buildout to pay for itself.

The immediate trigger came from across the Atlantic. A hotter-than-expected US inflation reading revived expectations of further rate hikes, and capital-intensive technology names bore the brunt. Reuters also flagged fresh weakness in Asian tech stocks, adding to the sour mood. None of this amounts to a Nebius-specific announcement, and treating a rate-driven pullback as evidence of collapsing demand or a failed project would be a misreading. Yet the funding question cannot be waved away as mere market noise. When a company's expansion depends on external capital, the cost of that capital belongs in the economic equation, not in a footnote.

Rotterdam: Intent, Not Yet Concrete

The distinction between ambition and execution is nowhere sharper than in Nebius's letter of intent with Volt Datacenters. The company aims to take over a "significant portion" of a planned 600 megawatt AI data center campus on Rotterdam's Maasvlakte. Press reports, however, note that construction remains uncertain, with the project subject to permitting and financing conditions.

That makes the agreement a statement of direction rather than a secured commitment. In the current rate environment, those caveats deserve at least as much weight as the headline capacity figure. A project can be strategically compelling without its realization being a foregone conclusion — and for investors, that is a more useful dividing line than a blanket verdict on the entire AI theme.

The Capital Bill Behind the Growth Story

The scale of what Nebius intends to spend is what gives the funding debate its edge. The company has penciled in capital expenditures of $20–25 billion for 2026. Judging the business purely on revenue growth leaves that prerequisite out of the picture entirely.

Rosenblatt's numbers illustrate the gap. The firm cites a free cash flow of -$3.41 billion for the reported second quarter and does not expect positive free cash flow until 2034. That is a forecast, not a fixed schedule — but it marks the central caveat sitting behind the same analyst's otherwise bullish stance. For anyone holding the stock, the long wait matters more than any single down day, because it means operational progress and financing must be assessed side by side over an extended horizon.

The Demand Case Is Real — and Substantial

None of this erases the other side of the ledger. Rosenblatt points to quarterly revenue of $582.3 million, up 454% year over year, alongside adjusted EBIT of $236.2 million. Those are meaningful counterweights to the financing worries and argue against the idea that Nebius is an abstract wager on demand that may never arrive. The business is already growing at a striking clip.

Microsoft and Meta together account for more than half of a reported order backlog exceeding $40 billion, according to the same research house. That gives the growth thesis concrete anchors. Still, a backlog describes business potential, not cash in hand — and the buildout must be funded today regardless of when those contracts convert. The two things belong together without being the same thing.

Funding Has Already Taken Several Forms

Nebius has not been idle on the financing front. The company issued $5.75 billion in convertible bonds and raised more than $2 billion through a share placement in 2026. Those moves show that the expansion is already drawing on multiple funding channels.

Part of the sector's jitters traces back to concerns over CoreWeave's bonds. That is not proof of identical risk at Nebius, and lumping the two together would be as misleading as exempting Nebius from the funding conversation simply because of its growth rate.

Analyst Optimism and Insider Selling, Side by Side

Rosenblatt initiated coverage of Nebius with a buy rating and a $304 price target — on October 8 in one account, October 7 in another. Either way, it is an analyst opinion, not a guarantee of where the shares will trade. Separately, an insider sale drew attention, though it was executed under a Rule 10b5-1 trading plan adopted on June 15. Reading that transaction as a spontaneous response to the recent rate debate would be a stretch; the documented plan is the more relevant context.

Weighing it all up, the valuation caution currently carries the day. The demand base is convincing, but the capital requirement sets a high bar. A falling share price does not make Nebius automatically more attractive. What would support a more durable valuation is tangible progress on the relationship between buildout, financing, and free cash flow. Until then, the growth story stands strong — its financial test of fire remains open.